Entities / Company
Pacific Biosciences.
biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation
- Reports this week
- 0
- Active events
- 0
- Connections
- 76
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
Pacific Biosciences CEO Christian Henry reported strong revenue growth for the company, attributing it to the adoption of the Vega system, while also addressing funding uncertainties.Some support5 reports1 development inside
-
ManpowerGroup and Pacific Biosciences were listed on the Nasdaq stock exchange on August 4, 2026.Some support1 report
-
Pacific Biosciences traded on the NASDAQ stock exchange on July 6, 2026.Some support1 report
Gone quiet
No new reports in 90+ days-
A market report published from Dublin details advanced molecular diagnostics and key players in the hemato-oncology testing market.Some support1 report
-
Trump pledged to unleash American oil and gas production, involving Pacific Biosciences.Some support1 report
-
Thredup, Boeing, and Pacific Biosciences are noted as examples of unprofitable, high-growth technology companies.Speculative1 report
-
Surgery Partners and Pacific Biosciences were both mentioned in the context of healthcare industry performance in July 2025.Speculative1 report
-
Pacific Biosciences (PacBio) shares plunged on August 9, 2025, while the S&P 500 increased. The company faced headwinds regarding Americas revenue and was discussing Revio and Vega placements.Some support2 reports2 developments inside
-
Johns Hopkins University, the University of Washington, and Pacific Biosciences are collaborating on sequencing projects contributing to the 1000 Genomes Project.Some support1 report
-
MBRU is an early customer of PacBio's Revio technology, with Christian Henry serving as CEO of PacBio.Some support1 report
-
Quest Diagnostics and Athena Diagnostics developed an ataxia test using PacBio technology.Some support1 report
-
PacBio collaborated with University of Washington researchers to benchmark and improve Google's DeepVariant accuracy.Some support2 reports
-
Illumina, Pacific Biosciences, Microsoft, and Monster Beverage were mentioned as thematic investing winners in the life sciences tools and services segment.Some support2 reports
-
Pacific Biosciences shares underperformed the market on August 8, 2025.Some support1 report
-
Pacific Biosciences published a Platinum Pedigree benchmark in Nature Methods and joined the 1000 Genomes Long Read Project.Some support1 report
-
Pacific Biosciences and EpiCypher partnered to accelerate epigenomics research, adopting the Fiber-Seq workflow.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around Pacific Biosciences this week
News at the entities that move Pacific Biosciences most-
SEC StructuralDHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Moves Pacific Biosciences
-
Nasdaq StructuralApple Inc. stock is traded on Nasdaq, and Jefferies Financial Group restated a hold rating on the company.Moves Pacific Biosciences
-
Morgan Stanley OperationalFinancial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Moves Pacific Biosciences
-
University of Washington OperationalUW researchers, co-directed by Allard, analyzed state election data using the UW Elections Database Project.Moves Pacific Biosciences
Connections
The 7 strongest of 76, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Mark Van Oene Structural
Mark Van Oene serves as the Chief Executive Officer of Pacific Biosciences.
-
Christian Henry Structural
Christian Henry serves as the CEO of Pacific Biosciences.
-
Nasdaq Structural
Pacific Biosciences is formally listed on the Nasdaq stock exchange.
-
SEC Structural
Pacific Biosciences is subject to formal regulation by the SEC regarding stock transaction filings.
-
EpiCypher (United States) Operational
EpiCypher partners with Pacific Biosciences, supplying enzymes used in PacBio HiFi systems for epigenomics research.
-
University of Washington Operational
Pacific Biosciences and the University of Washington engage in collaborative research projects.
-
Morgan Stanley Operational
Morgan Stanley discussed Pacific Biosciences' company strategy during an investment bank call.
History
Events by the month they beganAugust 2026
1 eventJune 2026
14 events- Pacific Biosciences CEO Christian Henry reported strong revenue growth for the company, attributing it to the adoption of the Vega system, while also addressing funding uncertainties.
- A market report published from Dublin details advanced molecular diagnostics and key players in the hemato-oncology testing market.
- Trump pledged to unleash American oil and gas production, involving Pacific Biosciences.
- Thredup, Boeing, and Pacific Biosciences are noted as examples of unprofitable, high-growth technology companies.
- Surgery Partners and Pacific Biosciences were both mentioned in the context of healthcare industry performance in July 2025.
- Pacific Biosciences (PacBio) shares plunged on August 9, 2025, while the S&P 500 increased. The company faced headwinds regarding Americas revenue and was discussing Revio and Vega placements.
- Johns Hopkins University, the University of Washington, and Pacific Biosciences are collaborating on sequencing projects contributing to the 1000 Genomes Project.
- MBRU is an early customer of PacBio's Revio technology, with Christian Henry serving as CEO of PacBio.
- Quest Diagnostics and Athena Diagnostics developed an ataxia test using PacBio technology.
- PacBio collaborated with University of Washington researchers to benchmark and improve Google's DeepVariant accuracy.
- Illumina, Pacific Biosciences, Microsoft, and Monster Beverage were mentioned as thematic investing winners in the life sciences tools and services segment.
- Pacific Biosciences shares underperformed the market on August 8, 2025.
- Pacific Biosciences published a Platinum Pedigree benchmark in Nature Methods and joined the 1000 Genomes Long Read Project.
- Pacific Biosciences and EpiCypher partnered to accelerate epigenomics research, adopting the Fiber-Seq workflow.